Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies.

Bacher U, Haferlach C, Schnittger S, Kohlmann A, Kern W, Haferlach T

Open source

DOI
10.1007/s00277-010-0920-6
Published
2010 Jul
Container
Annals of hematology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00277-010-0920-6,
  title = {Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies.},
  author = {Bacher U and Haferlach C and Schnittger S and Kohlmann A and Kern W and Haferlach T},
  year = {2010},
  journal = {Annals of hematology},
  doi = {10.1007/s00277-010-0920-6},
  url = {https://doi.org/10.1007/s00277-010-0920-6}
}

RIS

TY  - JOUR
TI  - Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies.
AU  - Bacher U
AU  - Haferlach C
AU  - Schnittger S
AU  - Kohlmann A
AU  - Kern W
AU  - Haferlach T
PY  - 2010
JO  - Annals of hematology
DO  - 10.1007/s00277-010-0920-6
UR  - https://doi.org/10.1007/s00277-010-0920-6
ER  - 

APA

U, B., C, H., S, S., A, K., W, K., & T, H. (2010). Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies.. Annals of hematology. https://doi.org/10.1007/s00277-010-0920-6

Source records